Healthcare provider profile · identity verified

Earl Potts, MD

Internal Medicine · N DARTMOUTH, MA · NPI 1679560791

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	439	113
Rosuvastatin Calcium	Rosuvastatin Calcium	436	120
Lisinopril	Lisinopril	400	108
Amlodipine Besylate	Amlodipine Besylate	295	80
Omeprazole	Omeprazole	274	84
Prednisone	Prednisone	241	134
Pravastatin Sodium	Pravastatin Sodium	232	61
Levothyroxine Sodium	Levothyroxine Sodium	208	55
Simvastatin	Simvastatin	199	58
Losartan Potassium	Losartan Potassium	194	54
Pantoprazole Sodium	Pantoprazole Sodium	187	55
Ezetimibe	Ezetimibe	180	51
Metformin Hcl Er	Metformin Hcl	168	47
Metoprolol Succinate	Metoprolol Succinate	159	44
Furosemide	Furosemide	156	37
Lorazepam	Lorazepam	135	20
Metformin Hcl	Metformin Hcl	124	35
Hydrochlorothiazide	Hydrochlorothiazide	123	37
Trazodone Hcl	Trazodone Hcl	120	32
Ozempic	Semaglutide	109	20
Escitalopram Oxalate	Escitalopram Oxalate	105	28
Alprazolam	Alprazolam	103	28
Albuterol Sulfate Hfa	Albuterol Sulfate	97	33
Lovastatin	Lovastatin	92	21
Montelukast Sodium	Montelukast Sodium	90	21
Metoprolol Tartrate	Metoprolol Tartrate	87	32
Tramadol Hcl	Tramadol Hcl	87	24
Sertraline Hcl	Sertraline Hcl	86	21
Methylprednisolone	Methylprednisolone	85	72
Triamcinolone Acetonide	Triamcinolone Acetonide	85	45
Eliquis	Apixaban	84	18
Allopurinol	Allopurinol	82	24
Glipizide	Glipizide	81	17
Nystatin	Nystatin	77	25
Gabapentin	Gabapentin	73	29
Warfarin Sodium	Warfarin Sodium	73	12
Tamsulosin Hcl	Tamsulosin Hcl	64	22
Potassium Chloride	Potassium Chloride	59	16
Labetalol Hcl	Labetalol Hcl	58	12
Doxycycline Hyclate	Doxycycline Hyclate	57	42
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	57	19
Nifedipine Er	Nifedipine	52	12
Ibuprofen	Ibuprofen	50	16
Doxazosin Mesylate	Doxazosin Mesylate	48	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	47	38
Meloxicam	Meloxicam	41	11
Mupirocin	Mupirocin	41	32
Atenolol	Atenolol	40	14
Citalopram Hbr	Citalopram Hydrobromide	39	11
Trulicity	Dulaglutide	39	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	38	11
Bumetanide	Bumetanide	36	suppressed
Famotidine	Famotidine	36	suppressed
Fluticasone Propionate	Fluticasone Propionate	36	12
Jardiance	Empagliflozin	36	11
Clopidogrel	Clopidogrel Bisulfate	35	suppressed
Spironolactone	Spironolactone	35	11
Celecoxib	Celecoxib	34	12
Paroxetine Hcl	Paroxetine Hcl	34	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	33	suppressed
Naproxen	Naproxen	32	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	32	20
Advair Hfa	Fluticasone Propion/Salmeterol	31	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	31	26
Hydralazine Hcl	Hydralazine Hcl	30	suppressed
Clonidine Hcl	Clonidine Hcl	29	suppressed
Finasteride	Finasteride	29	suppressed
Januvia	Sitagliptin Phosphate	29	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	29	suppressed
Donepezil Hcl	Donepezil Hcl	27	suppressed
Irbesartan	Irbesartan	27	suppressed
Klor-Con M20	Potassium Chloride	26	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	24	suppressed
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	23	suppressed
Glipizide Er	Glipizide	23	suppressed
Lactulose	Lactulose	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Enalapril Maleate	Enalapril Maleate	22	suppressed
Hydrocortisone	Hydrocortisone	22	suppressed
Meclizine Hcl	Meclizine Hcl	21	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Duloxetine Hcl	Duloxetine Hcl	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Alendronate Sodium	Alendronate Sodium	19	suppressed
Cephalexin	Cephalexin	19	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	19	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Carvedilol	Carvedilol	18	suppressed
Fenofibrate	Fenofibrate	18	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	18	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	16	suppressed
Clonazepam	Clonazepam	16	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Valsartan	Valsartan	15	suppressed
Carbamazepine	Carbamazepine	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Primidone	Primidone	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	13	suppressed
Azithromycin	Azithromycin	12	12
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Icosapent Ethyl	Icosapent Ethyl	11	suppressed
Jantoven	Warfarin Sodium	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Terbinafine Hcl	Terbinafine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error